Digital Health for Obesity - Global Strategic Business Report

The global market for Digital Health for Obesity was estimated at US$56.5 Billion in 2024 and is projected to reach US$168.7 Billion by 2030, growing at a CAGR of 20.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Digital Health for Obesity market.

Global Digital Health for Obesity Market - Key Trends & Drivers Summarized

Can AI-Powered Health Apps Tackle the Global Obesity Epidemic?

The global obesity crisis is being addressed through the rapid adoption of AI-powered digital health solutions that offer personalized weight management programs. Traditional weight loss approaches often fail due to a lack of personalization, accountability, and long-term behavioral support. Digital health applications are now integrating AI-driven meal planning, metabolic tracking, and behavioral coaching to create adaptive weight loss programs tailored to individual needs. AI algorithms analyze users’ dietary habits, physical activity levels, and metabolic responses to provide customized nutrition and fitness recommendations. Additionally, digital coaching platforms such as Noom and Lark use AI-powered chatbots to provide real-time motivation and adherence support. While these solutions enhance accessibility and personalization, concerns regarding the accuracy of AI-driven recommendations and the long-term sustainability of digital weight management strategies remain. Nevertheless, as AI-driven health coaching continues to advance, it is expected to play a critical role in combating obesity, reducing healthcare costs, and improving public health outcomes.

How Is Remote Monitoring Enhancing Weight Management?

The integration of remote monitoring tools in obesity management is significantly improving patient outcomes by enabling continuous tracking of vital health metrics such as weight fluctuations, calorie intake, and physical activity levels. Wearable fitness trackers and smart scales connected to mobile applications allow users to monitor their progress in real-time, promoting adherence to weight loss programs. Continuous glucose monitoring (CGM) technology is also emerging as a key component of personalized obesity management, providing insights into how different foods affect blood sugar levels and metabolic responses. Telehealth services are further enhancing access to obesity care by connecting patients with nutritionists, endocrinologists, and behavioral therapists remotely. However, while remote monitoring solutions provide valuable data-driven insights, challenges such as user engagement retention, data privacy, and device affordability still need to be addressed. As technology improves and remote health monitoring becomes more seamless, digital solutions for obesity management are expected to become increasingly effective, paving the way for more sustainable weight loss outcomes.

Are Digital Therapeutics (DTx) the Future of Obesity Treatment?

Digital therapeutics (DTx) are emerging as an evidence-based approach to treating obesity by addressing behavioral, psychological, and physiological factors contributing to weight gain. Unlike traditional diet apps, DTx solutions are clinically validated and designed to provide structured interventions for weight loss, often incorporating behavioral modification techniques such as cognitive behavioral therapy (CBT) and habit-tracking algorithms. AI-powered metabolic health platforms, such as Virta Health, use continuous patient data to optimize dietary interventions, improving long-term weight loss success rates. Additionally, virtual coaching programs and mobile-based interventions are being integrated with weight-loss medications to enhance adherence and improve efficacy. Despite the potential of DTx in obesity management, regulatory approvals, reimbursement policies, and long-term efficacy studies remain key hurdles. However, as more clinical evidence supports the effectiveness of digital obesity treatments, adoption is expected to grow, leading to a paradigm shift in obesity care.

What Is Driving the Growth of the Digital Health for Obesity Market?

The growth in the digital health for obesity market is driven by several key factors, including increasing obesity prevalence, rising healthcare costs, and advancements in AI-driven weight management solutions. The adoption of wearable health devices and mobile health applications is making personalized weight management more accessible and scalable. The expansion of telehealth services and virtual coaching programs is improving patient engagement, reducing the need for in-person consultations. The integration of AI, behavioral science, and data analytics is enabling more effective, individualized weight-loss interventions. Regulatory support for digital therapeutics and increasing insurance coverage for digital weight management programs are further driving market adoption. Additionally, growing investment in digital health startups specializing in metabolic health is accelerating innovation in obesity care. As obesity rates continue to rise globally, digital health solutions are expected to play a crucial role in providing cost-effective, scalable, and evidence-based interventions for sustainable weight management.

Report Scope

The report analyzes the Digital Health for Obesity market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Component (Software Component, Hardware Component, Services); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Software Component segment, which is expected to reach US$87.4 Billion by 2030 with a CAGR of a 17.7%. The Hardware Component segment is also set to grow at 23.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $15.4 Billion in 2024, and China, forecasted to grow at an impressive 26.6% CAGR to reach $39.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Digital Health for Obesity Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Health for Obesity Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Digital Health for Obesity Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Calibrate, DarioHealth, Daphne Platform, Digital Therapeutics Alliance, Eli Lilly and Company and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 41 Featured):

• Calibrate
• DarioHealth
• Daphne Platform
• Digital Therapeutics Alliance
• Eli Lilly and Company
• Fitbit
• Form Health
• Found
• Hinge Health
• Kurbo Health
• Lark Health
• Noom
• Omada Health
• Ro
• Soleno Therapeutics
• Teladoc Health
• Vida Health
• WW International
• Xenetic Biosciences

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry